Background: Subcutaneous implantation of a macroencapsulated patch containing
overall diffusion for islet cells, while macroencapsulation, that is holding the islets in a single major device, offers the advantage of easy retrieval and even fresh cell replenishment if necessary. Alginate is probably the most studied biomaterial for islet encapsulation due to its biocompatibility, selective permeability and the possibility to use it in both micro-and macroencapsulation techniques. In 2011, Basta et al 1 were the first to report successful microencapsulated islet allotransplantation in 4 non-immunosuppressed diabetic patients with improvement of glycaemia and HbA 1c as well as reduced exogenous insulin requirements over a follow-up period of 3 years.
Human clinical trials of microencapsulated porcine islets conducted in New Zealand (NZ) and Argentina have also reported no evidence of pathogen transmission but limited efficacy, with patients exhibiting a ≥50% reduction in hypoglycaemic episodes after 1 year when compared with control groups.
2,3
The alginate-encapsulated monolayer device is composed of decellularized allogeneic (human fascia lata) or xenogeneic (porcine acellular dermis) collagen on which porcine islets are seeded.
The ensemble is then embedded in alginate to constitute a patch of macroencapsulated islets. Non-human primate studies have demonstrated this approach as successful in correcting chemically induced diabetes for up to 6 months. 4 Despite the in vivo success of T1DM correction using encapsulated porcine islets, some concerns still remain in regards to safety, in particular, the possible transmission of porcine endogenous retrovirus (PERV).
Data from the NZ trial 2 and Argentinian trial 5 have demonstrated an absence of PERV in recipients of porcine encapsulated islets.
However, it is worth noting that in both instances the human and primate recipients were immunocompetent. Thus, it is difficult to determine if the absence of PERV is due to the impermeability of the alginate to the virus or the efficiency of the immune system in targeting PERV escaping the patch. Given the lack of studies examining permeability of alginate patches to viruses, for this study, we deemed it appropriate to determine if the encapsulation technology would prevent the release of PERV using an in-vitro coculture model.
| MATERIAL S AND ME THODS

| Isolation and preparation of islets
Pancreatic islets were isolated from adult Landrace (2-3 year old)
pigs (RA-SE genetics, Belgium) and cultured in vitro for 24-72 hours as previously described 6 before undergoing encapsulation. A total of 5000 islet equivalents (IEQ) or 25 000 cells (PK15) were seeded on a collagen matrix (acellular porcine dermis), covered with a 300 μm mesh, stabilized with surgical clips and coated with 3% sterile lyophilized high mannuronic acid content (SLM) alginate solution with a permeability up to 150 kDa (Novamatrix, Norway). 7 The patch was immersed in MOPS (3-(N-morpholino)propanesulfonic acid)
buffer + 100 μmol/L CaCl 2 for 7 minutes to allow alginate polymerization, then washed in MOPS for 5 minutes and transferred to CMRL culture medium (Mediatech, USA) supplemented with 10%
heat-inactivated foetal bovine serum (FBS), 1% penicillin and 1% streptomycin (stock concentration 10 000 U/mL; all from Westburg, the Netherlands). 
| Co-culture for PERV transmission
| PERV screening
The presence of PERV RNA and RT were used as indicators of PERV release from donor cells (encapsulated or free), into the cell medium shared with target cells. Supernatant samples were assayed for the presence of PERV RNA using a TaqMan based qRT-PCR targeting the pol region using QuantiTect ® virus reagents (Qiagen, Crawley, UK) and Viia7 real time cycler (Thermo Fisher, Paisley, UK), primers and cycling conditions are previously described. 7 SG-PERT was used to detect RT, using murine leukaemia virus RT as a standard and a method previously described. 8 Capsid integrity testing was carried out to distinguish between intact virions and cell-derived TaqMan qPCR with QuantiTect virus reagents ® and a Viia7 real time cycler (Thermo Fisher), as described previously. 7 Statistical analysis was carried out using an unpaired student's t test.
| RE SULTS
As described in the methods, supernatant samples were collected on a weekly basis from each experiment 1-9 in triplicate (Table 1) and assayed for PERV RNA and RT (Figures 1 and 2) . A significant increase in RT was detected by SG-PERT analysis in ST cell culture media exposed to free PK15 cells (Experiment 6), in comparison with ST cell only controls (Experiment 8) over time (week 4 P = .0284, week 6 P < .0001, week 8 P < .0001; Figure 1A ). However, ST cells exposed to encapsulated islet and PK15 cells did not show RT levels higher than the ST negative control cells at any time point over the 8-week period ( Figure 1A ).
Analysis of HEK293 culture media shows high RT levels (48 266 SD ± 13 370 μURT/mL; range 40 708-63 704 μURT/mL) in cell culture supernatant from HEK293 cells exposed to free PK15 cells at weeks 
| D ISCUSS I ON
Previous work had demonstrated that this device was permeable to small molecules like insulin but constituted an efficient barrier to microbes or large cell fragments and impurities during its subcutaneous to susceptible cell lines 9, 10 and in vivo studies which reported an absence of PERV in encapsulated porcine islet recipients. 2, 5, 7, [11] [12] [13] [14] [15] [16] This would suggest that islets are low risk for PERV release and infection and along with encapsulation, this could reduce the risk even more. Indeed, it has also been suggested that islets may not harbour many of the viral pathogens identified in the donor pig. 17 However, we recognize that this study was conducted for a relatively short time period of 8 weeks and that a longer study would be valuable in examining this further. Although, it should be noted that PK15 cells used in this study are high PERV producers and it is likely a lower barrier of protection is required to protect as against PERV transmission from islet cells. 
Mean intact PERV
293+ islet patch 1 Results of capside integrity analysis, as determined by ultracentrifugation followed by Rnase treatment and qRT-PCR of individual replicates from HEK293 co-cultured experiments for weeks 2, 4, 6 and 8, + indicates that intact PERV virions were detected. Thus, intact PERV was detected in all triplicates of HEK293 cells exposed to free PK15 cells at weeks 2, 4, 6 and 8 and in 1 replicate of the HEK293 cells exposed to encapsulated PK15 cells at weeks 6 and 8.
Unfortunately, a limitation of the study is that we did not confirm the viability of the cells post-experiment to determine if cells were still viable after the 8-week period. We also do not know if the prepared device for macroencapsulation had been subject to any degradation or breach during the experiment. We do know that macroencapsulated islet cells survive for long periods in vivo 4 and that the alginate matrix used in this study has been fully evaluated. 18 The islet cells used in these experiments were macroencapsulated, which utilizes alginate at a 3% concentration.
In the case of islet microencapsulation, an alginate concentration of 1%-1.5% is usually utilized. Whether this change in alginate concentration would impact the protection the device offers to PERV release remains unknown. However, the permeability of the device is thought to be related more to the gelling solution, rather than the alginate concentration. 19 In addition, the perme- 
